clonidine has been researched along with h 89 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sugimoto, M; Uchida-Oka, N | 1 |
Azad, SC; DeBock, F; Hapfelmeier, G; Kurz, J; Parsons, CG; Rammes, G; Zieglgänsberger, W | 1 |
Kang, JF; Lang, B; Li, H; Li, YQ | 1 |
Chartier, D; Ehrlich, JR; HĂ©bert, TE; Nattel, S; Qi, X; Yeh, YH | 1 |
Bao, JY; Huang, HW; Huang, Y; Peng, YP; Qiu, YH; Xiao, J | 1 |
5 other study(ies) available for clonidine and h 89
Article | Year |
---|---|
Norepinephrine induces apoptosis in skin melanophores by attenuating cAMP-PKA signals via alpha2-adrenoceptors in the medaka, Oryzias latipes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apoptosis; Clonidine; Colforsin; Culture Techniques; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cysteine Proteinase Inhibitors; Isoquinolines; Melanophores; Norepinephrine; Oligopeptides; Oryzias; Phenylephrine; Prazosin; Protein Isoforms; Receptors, Adrenergic, alpha-2; Signal Transduction; Skin; Skin Pigmentation; Sulfonamides; Yohimbine | 2001 |
Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclase Inhibitors; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amygdala; Animals; Barium; Cadmium; Calcium Channel Blockers; Calcium Channels; Clonidine; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 4; Electric Stimulation; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Heterotrimeric GTP-Binding Proteins; Imines; In Vitro Techniques; Isoquinolines; Long-Term Potentiation; Long-Term Synaptic Depression; Membrane Potentials; Mice; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxins; Patch-Clamp Techniques; Pertussis Toxin; Piperazines; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pyridines; Receptors, Adrenergic, alpha-2; Serotonin Antagonists; Sulfonamides; Yohimbine | 2003 |
Alpha-2 adrenoceptor mediating the facilitatory effect of norepinephrine on the glycine response in the spinal dorsal horn neuron of the rat.
Topics: Alkaloids; Animals; Benzophenanthridines; Clonidine; Dose-Response Relationship, Drug; Drug Combinations; Electric Conductivity; Enzyme Inhibitors; Glycine; Isoquinolines; Neurons; Norepinephrine; Nystatin; Patch-Clamp Techniques; Phenanthridines; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sulfonamides; Yohimbine | 2003 |
Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes.
Topics: Acetylcholine; Action Potentials; Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bee Venoms; Clonidine; Cyclic AMP-Dependent Protein Kinases; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Estrenes; Heart Atria; Imidazoles; Indoles; Isoproterenol; Isoquinolines; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Phenylephrine; Phorbol 12,13-Dibutyrate; Piperazines; Potassium Channels; Prazosin; Propanolamines; Propranolol; Protein Kinase C; Pyrrolidinones; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Sulfonamides; Type C Phospholipases | 2007 |
Modulation of natural killer cell function by alpha-adrenoreceptor-coupled signalling.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Clonidine; Cytotoxicity Tests, Immunologic; Estrenes; Flow Cytometry; Intracellular Signaling Peptides and Proteins; Isoquinolines; Killer Cells, Natural; Phenylephrine; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Spleen; Sulfonamides; Type C Phospholipases; Yohimbine | 2010 |